Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
13 participants
OBSERVATIONAL
2024-04-15
2024-06-05
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Choroidal Thickness in Myopes by SSOCT
NCT03542448
Vitreomacular Interface Abnormalities in Diabetic Retinopathy Using OCT
NCT03686436
Correlation Between OCT and mFERG Findings With VA After Vitrectomy Surgery for Retinal Detachment
NCT05993208
Measuring Choroidal Thickness Using Optical Coherence Tomography
NCT06272851
Optical Coherence Tomography Angiography in Myopic Patients
NCT04135209
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* anterior segment optical coherence tomography is performed preoperative and 1 month postoperative to assess healing
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
cases after surgical management
cases are assessed by Anterior segment optical coherence tomography 1 month after surgical managemnt
anterior segment optical coherence tomography
surgically treated corneal perforation by amniotic membrane graft and platelet rich plasma clot is assessed by anterior segment optical coherence tomography 1 month postoperative
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
anterior segment optical coherence tomography
surgically treated corneal perforation by amniotic membrane graft and platelet rich plasma clot is assessed by anterior segment optical coherence tomography 1 month postoperative
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* small corneal perforation
Exclusion Criteria
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Minia University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ahemd Abdelghany
Associate professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ahmed A Abdelghany, professor
Role: PRINCIPAL_INVESTIGATOR
professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Faculty of Medicine
Minya, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Abdelghany AA, Bahrawy ME, Alio JL. Combined Platelet Rich Plasma and Amniotic membrane in the treatment of Perforated Corneal Ulcers. Eur J Ophthalmol. 2022 Jul;32(4):2148-2152. doi: 10.1177/11206721211049100. Epub 2021 Oct 8.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1133/04/2024
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.